1. Home
  2. TWG vs PPBT Comparison

TWG vs PPBT Comparison

Compare TWG & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWG
  • PPBT
  • Stock Information
  • Founded
  • TWG 2009
  • PPBT 2010
  • Country
  • TWG Hong Kong
  • PPBT Israel
  • Employees
  • TWG N/A
  • PPBT N/A
  • Industry
  • TWG
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWG
  • PPBT Health Care
  • Exchange
  • TWG NYSE
  • PPBT Nasdaq
  • Market Cap
  • TWG 7.7M
  • PPBT 7.1M
  • IPO Year
  • TWG 2024
  • PPBT N/A
  • Fundamental
  • Price
  • TWG $0.14
  • PPBT $2.73
  • Analyst Decision
  • TWG
  • PPBT Strong Buy
  • Analyst Count
  • TWG 0
  • PPBT 1
  • Target Price
  • TWG N/A
  • PPBT $33.00
  • AVG Volume (30 Days)
  • TWG 11.7M
  • PPBT 16.2K
  • Earning Date
  • TWG 02-15-2025
  • PPBT 05-20-2025
  • Dividend Yield
  • TWG N/A
  • PPBT N/A
  • EPS Growth
  • TWG N/A
  • PPBT N/A
  • EPS
  • TWG 0.02
  • PPBT N/A
  • Revenue
  • TWG $14,375,689.00
  • PPBT N/A
  • Revenue This Year
  • TWG N/A
  • PPBT N/A
  • Revenue Next Year
  • TWG N/A
  • PPBT N/A
  • P/E Ratio
  • TWG $8.09
  • PPBT N/A
  • Revenue Growth
  • TWG 21.97
  • PPBT N/A
  • 52 Week Low
  • TWG $0.13
  • PPBT $2.00
  • 52 Week High
  • TWG $13.50
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • TWG N/A
  • PPBT 51.95
  • Support Level
  • TWG N/A
  • PPBT $2.67
  • Resistance Level
  • TWG N/A
  • PPBT $2.75
  • Average True Range (ATR)
  • TWG 0.00
  • PPBT 0.21
  • MACD
  • TWG 0.00
  • PPBT 0.04
  • Stochastic Oscillator
  • TWG 0.00
  • PPBT 67.19

About TWG TOP WEALTH GROUP HLDG LTD

Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: